Immunotherapy has revolutionized the way physicians treat patients. Previously, chemotherapy was the standard-of-care with the goal to eliminate tumor cell | Immunology ...
This article is based on a poster originally authored by Weiping Sun, Xing Zhang, Zhaolu Yan, Chen Yu, Spencer Chiang, and Tianfu Zhang. Immunotherapy is an advanced and widely used treatment due to ...
Janux Therapeutics is a biopharmaceutical company developing novel immunotherapies to fight cancer, with promising drug candidates targeting PSMA and EGFR. JANX's TRACTr and TRACIr platforms engineer ...
From mutation to medicine: How neoantigen dendritic cell vaccines are reshaping cancer immunotherapy
A new generation of personalized cancer vaccines is taking shape through the use of neoantigen-based dendritic cell (DC) vaccines.
T cells are vital for surveillance within the immune system. They are activated once the T cell receptor (TCR) binds its cognate peptide found in cell surface proteins encoded by the major ...
Cellular therapies, including TIL, TCR, and CAR-T, are transforming lung cancer care by utilizing personalized immune cells to target tumors. TIL therapy, now FDA-approved for solid tumors, shows ...
All cells need to sense and respond to their environment, to know when to activate genes, build proteins, and carry out their ...
Issued on behalf of GT Biopharma, Inc. VANCOUVER, BC, Oct. 17, 2025 /PRNewswire/ -- Equity InsiderNews Commentary – MIT and Harvard scientists recently created engineered CAR-NK cells that hide from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback